Monitoring of clinical trials and interim analyses from a drug Sponsor's point of view-Reference-Cited by-同舟云学术

Monitoring of clinical trials and interim analyses from a drug Sponsor's point of view

Published:1993-03 Issue:5-6 Volume:12 Page:481-492
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Williams George W.,Davis Robert L.,Getson Albert J.,Gould A. Lawrence,Hwang Irving K.,Matthews Holly,Shih Weichung Joseph,Snapinn Steven M.,Walton-Bowen Karen L.

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Reference36 articles.

1. and Fundamentals of Clinical Trials, 2nd edn, DSG Publishing Co. Inc., 1985.

2. Interim analysis in clinical trials

3. Interim Analyses in Randomized Clinical Trials: Ramifications and Guidelines for Practitioners

4. ‘Multiple looks and interim analyses from a drug sponsor's point of view’, presented at International Statistical Institute 48th Session, Cairo, Egypt, 15 September, 1991.

5. and ‘Interim analyses in clinical trials’, to appear in and (eds.), Statistics in the Pharmaceutical Industry, 2nd edn, Marcel Dekker, New York, 1992.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sharing interim trial results by the Data Safety Monitoring Board with those responsible for the trial’s conduct and progress: a narrative review;Trials;2017-03-09

2. Monitoring Committee Structure and Function;Fundamentals of Clinical Trials;2015

3. References;Design and Analysis of Clinical Trials;2013-11-08

4. Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information;Contemporary Clinical Trials;2011-09

5. Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information;Contemporary Clinical Trials;2011-09